 | | | | U.S.-German genetic testing specialist Qiagen reported a surge in third-quarter profit on Wednesday, boosted by higher demand for its coronavirus tests amid a rise in infections due to the fast-spreading Delta variant. | | | | | | A proposed cap on out-of-pocket drug costs for Medicare recipients would improve patient access, but allowing the U.S. government health plan for seniors to negotiate prices could limit innovation, Amgen Inc Chief Executive Robert Bradway said in an interview. | | | | | | The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that have yet to be certified by peer review. | | | | | | French health authorities reported 10,050 daily new COVID-19 infections on Wednesday, the first time the tally has topped 10,000 since Sept 14. | | | | | | As soon as Anna Weber Kneitel learned San Francisco Bay Area pharmacies had opened appointments for COVID-19 vaccines for young children, she booked the closest one she could find for her 7-year-old son. | | | | | | Germany's Merck KGaA raised its full-year profit forecast on Wednesday, citing a very strong performance at its Life Science unit, which supplies materials and gear to COVID-19 vaccine makers and other drugmakers. | | | | | | The U.S. Labor Department will issue its national COVID-19 vaccine and testing rule for large employers in the coming few days, White House coronavirus response coordinator Jeff Zients said on Wednesday. | | | | | | Britain declared a nationwide Avian Influenza Prevention Zone on Wednesday, ordering farms and bird keepers to toughen their biosecurity measures after a number of cases of bird flu were spotted in wild birds. | | | | | | Denmark reported an outbreak of highly pathogenic H5 bird flu at a turkey farm in the central part of the country, the World Organisation for Animal Health (OIE) said on Wednesday. | | | | | | The country's first national COVID-19 vaccine mandate, expected to be unveiled by the Biden administration this week, is likely to unleash a frenzied legal battle that will hinge on a rarely used law and questions over federal power and authority over healthcare. | | | | | |
